In RRMS, the early course of the disease is characterised by intermittent relapses, and partial or complete recovery of function between exacerbations. The occurrence of relapses is a key measure of ...

The European Medicines Agency today released a new guideline titled, Guideline on similar biological medicinal products containing interferon beta. This guideline addresses the non-clinical and ...

Betaseron (interferon beta-1b) is a prescription drug that treats certain types of multiple sclerosis (MS) and clinically isolated syndrome in adults. It’s given as an injection under your skin.

Betaseron (interferon beta-1b) is a prescription drug used to treat certain types of multiple sclerosis (MS) and clinically isolated syndrome (CIS) in adults. The drug is given as an injection under ...

Treatment with dazukibart, a monoclonal antibody targeting interferon beta, yielded a rapid reduction in dermatomyositis disease activity in adults with skin-predominant and muscle-predominant ...

Treatment with interferon or with glatiramer acetate? This question arises for many patients who receive a diagnosis of multiple sclerosis (MS) for the first time. Until now, the choice between the ...

The MTA ‘Multiple sclerosis - interferon beta, glatiramer acetate (review TA32) [ID809]’ has been suspended to allow NICE to reconcile the submissions made by stakeholders and the Assessment Group ...